CSIMarket Company Name, Ticker, Industry, else..
 
Kairos Pharma Ltd   (NYSEAMER: KAPA)
 
Price: $1.7200 $-0.05 -2.825%
Day's High: $1.7798999547958374 Week Perf: -3.91 %
Day's Low: $ 1.72 30 Day Perf: 561.54 %
Volume (M): 42,249 52 Wk High: $ 1.91
Volume (M$): $ 0 52 Wk Avg: $0.72
Open: $1.77 52 Wk Low: $0.22



 Market Capitalization (Millions $) 37
 Shares Outstanding (Millions) 21
 Employees 4
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biopharmaceutical firm developing therapeutics, including antibodies and small molecules, to treat cancers such as prostate, lung, breast cancer, and glioblastoma by targeting immune suppression and drug resistance mechanisms. Its portfolio includes seven drug candidates, including those developed by its subsidiary Enviro Therapeutics, Inc. The company is conducting clinical trials for drugs such as ENV 105 and KROS 201 aimed at overcoming resistance to standard cancer therapies.


   Company Address: 2355 Westwood Blvd. Los Angeles 90064 CA
   Company Phone Number: 948-2356   Stock Exchange / Ticker: NYSEAMER KAPA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Pioneering Precision Oncology Kairos Pharmas Collaboration with PreCheck Health Services to Combat Cancer Drug Resis...

Published Tue, Sep 24 2024 8:20 PM UTC

In the rapidly evolving landscape of oncology, precision medicine stands out as a beacon of hope for enhancing treatment outcomes. An exciting development emerged with Kairos Pharma Ltd. s recent agreement with PreCheck Health Services Inc. This partnership focuses on the development of biomarkers to identify patients most likely to respond to ENV105, a targeted therapy aime...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 8.79
PEG (TTM) -

Financial Strength Current
Quick Ratio 19.12
Working Capital Ratio 19.64
Leverage Ratio (MRQ) 0.06
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.6 $
Revenues (TTM) -
Cash Flow (TTM) 0.03 $
Cash 0.24 $
Book Value 0.2 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,451,250
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.